CC — The Chemours Company

CC

The Chemours Company NYSE

Basic Materials ·Chemicals - Specialty ·US · chemours.com

$27.73

Mkt Cap $4.2B

52w Low $9.13 101.1% of range 52w High $27.52

50d MA $20.61 200d MA $15.81

P/E (TTM) -10.8x

EV/EBITDA 17.1x

P/B 16.6x

Debt/Equity 18.3x

ROE -18.8%

P/FCF 34.8x

RSI (14) —

ATR (14) —

Beta 1.40

50d MA $20.61

200d MA $15.81

Avg Volume 3.4M

About

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure and BaiMax brands for delivering whiten…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Feb 19, 2026	AMC	0.09	0.05	-43.6%	20.41	-8.7%	-16.5%	-11.7%	-9.8%	-11.7%	-15.1%	-9.4%	—
Nov 6, 2025	AMC	0.24	0.20	-16.7%	11.74	-3.1%	+6.6%	+8.6%	+7.8%	+7.4%	+4.5%	+3.9%	—
Aug 5, 2025	AMC	0.46	0.58	+26.1%	12.63	+4.7%	-5.0%	-3.6%	-3.5%	-7.5%	-1.7%	+19.5%	—
May 6, 2025	AMC	0.19	0.13	-31.6%	12.10	-14.7%	-9.9%	-7.1%	-8.6%	-0.9%	-2.6%	-11.9%	—
Feb 18, 2025	AMC	0.10	0.11	+10.0%	17.48	-4.3%	-1.8%	+0.0%	-4.1%	-7.6%	-9.6%	-16.1%	—
Nov 4, 2024	AMC	0.32	0.40	+25.0%	20.58	-2.1%	-3.4%	+0.7%	-0.6%	-3.8%	-3.7%	+3.4%	—
Aug 1, 2024	AMC	0.57	0.38	-33.3%	23.31	-13.8%	-11.9%	-19.6%	-19.7%	-23.5%	-21.7%	-20.1%	—
Apr 30, 2024	AMC	0.18	0.32	+77.8%	26.75	-0.5%	-2.8%	-2.2%	-0.7%	+2.3%	+4.6%	-4.3%	—
Mar 27, 2024	AMC	0.29	0.31	+6.9%	28.88	-13.4%	-9.1%	-0.5%	-4.4%	-0.5%	-5.5%	-5.4%	—
Oct 26, 2023	AMC	0.77	0.64	-16.9%	24.24	-1.1%	-2.7%	+2.0%	-0.5%	-1.2%	+0.8%	+8.0%	—
Jul 27, 2023	AMC	1.09	1.10	+0.9%	37.95	-1.4%	-3.6%	-2.6%	-2.9%	-3.5%	-3.6%	-11.9%	—
Apr 27, 2023	AMC	0.47	0.98	+108.5%	27.95	-1.1%	+4.0%	+6.5%	+8.6%	+4.4%	+2.0%	-0.8%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 28	Truist	Maintains	Buy → Buy	—	$26.48	$26.58	+0.4%	-2.9%	-0.5%	+1.8%	+4.7%	—
Apr 9	UBS	Maintains	Buy → Buy	—	$21.43	$21.34	-0.4%	+1.9%	+6.0%	+7.6%	+6.8%	+7.5%
Apr 9	Truist	Maintains	Buy → Buy	—	$21.43	$21.34	-0.4%	+1.9%	+6.0%	+7.6%	+6.8%	+7.5%
Mar 5	Mizuho	Maintains	Outperform → Outperform	—	$17.53	$17.71	+1.0%	-4.4%	-6.4%	-0.6%	+1.5%	+2.1%
Feb 25	Goldman Sachs	Maintains	Neutral → Neutral	—	$18.41	$18.59	+1.0%	-2.1%	-5.9%	-0.9%	-2.3%	-8.9%
Feb 23	UBS	Maintains	Buy → Buy	—	$17.04	$16.81	-1.3%	+5.8%	+8.0%	+5.8%	+1.6%	+7.0%
Feb 23	BMO Capital	Maintains	Outperform → Outperform	—	$17.04	$16.81	-1.3%	+5.8%	+8.0%	+5.8%	+1.6%	+7.0%
Feb 23	JP Morgan	Maintains	Neutral → Neutral	—	$17.04	$16.81	-1.3%	+5.8%	+8.0%	+5.8%	+1.6%	+7.0%
Feb 23	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$17.04	$16.81	-1.3%	+5.8%	+8.0%	+5.8%	+1.6%	+7.0%
Jan 21	Truist	Maintains	Buy → Buy	—	$15.26	$15.84	+3.8%	+6.1%	+5.1%	+3.2%	+3.5%	+2.4%
Dec 3	JP Morgan	Maintains	Neutral → Neutral	—	$12.77	$12.71	-0.5%	+1.5%	-1.8%	-0.5%	-4.5%	-2.9%
Nov 11	UBS	Maintains	Buy → Buy	—	$12.75	$12.75	+0.0%	-0.8%	-1.1%	-3.8%	-6.7%	-11.8%
Nov 10	RBC Capital	Maintains	Outperform → Outperform	—	$12.51	$12.62	+0.9%	+1.9%	+1.1%	+0.8%	-1.9%	-5.0%
Nov 10	Truist	Maintains	Buy → Buy	—	$12.51	$12.62	+0.9%	+1.9%	+1.1%	+0.8%	-1.9%	-5.0%
Oct 16	Mizuho	Maintains	Outperform → Outperform	—	$14.42	$14.29	-0.9%	-4.6%	-10.5%	-7.7%	-7.4%	-6.2%
Oct 6	UBS	Maintains	Buy → Buy	—	$16.13	$16.40	+1.7%	-2.0%	-6.4%	-6.8%	-14.8%	-22.2%
Sep 23	Mizuho	Maintains	Outperform → Outperform	—	$17.02	$17.21	+1.1%	-3.1%	-3.9%	-9.9%	-8.0%	-8.3%
Sep 16	Truist	Maintains	Buy → Buy	—	$17.26	$17.34	+0.5%	-1.0%	-0.5%	+1.6%	-1.4%	-1.4%
Jul 15	Mizuho	Maintains	Outperform → Outperform	—	$13.49	$13.73	+1.8%	-2.4%	-1.8%	+1.3%	+0.5%	+0.6%
Jul 3	RBC Capital	Maintains	Outperform → Outperform	—	$12.73	$13.02	+2.3%	+1.6%	-2.4%	+7.1%	+8.2%	+10.4%
May 28	Barclays	Maintains	Equal Weight → Equal Weight	—	$10.62	$10.57	-0.5%	-5.7%	-4.8%	-4.6%	-11.5%	-6.5%
May 14	Goldman Sachs	Maintains	Neutral → Neutral	—	$11.78	$11.63	-1.3%	-3.1%	-6.3%	-5.2%	-5.1%	-5.2%
May 12	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$11.06	$11.68	+5.6%	+8.4%	+6.5%	+3.3%	-0.2%	+1.0%
May 8	RBC Capital	Maintains	Outperform → Outperform	—	$10.90	$11.18	+2.6%	+3.1%	+1.5%	+10.0%	+8.1%	+4.8%
May 7	UBS	Maintains	Buy → Buy	—	$12.10	$10.32	-14.7%	-9.9%	-7.1%	-8.6%	-0.9%	-2.6%
Apr 14	Truist	Maintains	Buy → Buy	—	$11.28	$11.62	+3.0%	+2.1%	-1.5%	-2.3%	+0.7%	+0.4%
Apr 1	Barclays	Maintains	Equal Weight → Equal Weight	—	$13.53	$13.25	-2.1%	-4.2%	-3.5%	-15.6%	-21.5%	-22.2%
Mar 27	Mizuho	Upgrade	Neutral → Outperform	—	$13.83	$14.11	+2.0%	+3.3%	-0.8%	-2.2%	-6.3%	-5.6%
Feb 24	Barclays	Maintains	Equal Weight → Equal Weight	—	$16.76	$16.71	-0.3%	-3.6%	-5.7%	-4.5%	-9.3%	-10.8%
Feb 19	BMO Capital	Maintains	Outperform → Outperform	—	$17.48	$16.72	-4.3%	-1.8%	+0.0%	-4.1%	-7.6%	-9.6%
Jan 13	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$17.64	$17.66	+0.1%	+4.2%	+5.6%	+6.5%	+8.2%	+10.0%
Jan 7	Mizuho	Maintains	Neutral → Neutral	—	$16.93	$17.44	+3.0%	+10.8%	+5.7%	+4.2%	+8.6%	+10.0%
Jan 7	Goldman Sachs	Maintains	Neutral → Neutral	—	$16.93	$17.44	+3.0%	+10.8%	+5.7%	+4.2%	+8.6%	+10.0%
Dec 12	RBC Capital	Maintains	Outperform → Outperform	—	$19.42	$19.40	-0.1%	-0.1%	-2.0%	-3.4%	-6.2%	-10.6%
Nov 6	RBC Capital	Maintains	Outperform → Outperform	—	$19.88	$20.58	+3.5%	+4.2%	+2.9%	-0.5%	-0.4%	-2.9%
Nov 5	Barclays	Maintains	Equal Weight → Equal Weight	—	$20.58	$20.14	-2.1%	-3.4%	+0.7%	-0.6%	-3.8%	-3.7%
Nov 5	Morgan Stanley	Maintains	Equal Weight → Equal Weight	—	$20.58	$20.14	-2.1%	-3.4%	+0.7%	-0.6%	-3.8%	-3.7%
Oct 11	RBC Capital	Maintains	Outperform → Outperform	—	$19.78	$19.70	-0.4%	+3.0%	+0.9%	-1.4%	+0.4%	-0.1%
Oct 7	BMO Capital	Maintains	Outperform → Outperform	—	$19.57	$19.85	+1.4%	+2.6%	-0.2%	+0.5%	+1.1%	+4.1%
Sep 25	Barclays	Maintains	Equal Weight → Equal Weight	—	$19.55	$19.47	-0.4%	-4.4%	+6.4%	+6.0%	+3.9%	+0.8%
Sep 3	Goldman Sachs	Maintains	Neutral → Neutral	—	$19.44	$18.92	-2.7%	-4.2%	-4.7%	-4.8%	-10.1%	-12.0%
Aug 6	UBS	Maintains	Buy → Buy	—	$18.75	$18.75	+0.0%	-0.2%	-4.9%	-2.6%	-3.4%	-4.7%
Aug 6	BMO Capital	Maintains	Outperform → Outperform	—	$18.75	$18.75	+0.0%	-0.2%	-4.9%	-2.6%	-3.4%	-4.7%
Aug 6	Barclays	Maintains	Equal Weight → Equal Weight	—	$18.75	$18.75	+0.0%	-0.2%	-4.9%	-2.6%	-3.4%	-4.7%
Aug 6	JP Morgan	Maintains	Neutral → Neutral	—	$18.75	$18.75	+0.0%	-0.2%	-4.9%	-2.6%	-3.4%	-4.7%
Jul 9	UBS	Upgrade	Neutral → Buy	—	$22.32	$23.46	+5.1%	+0.6%	+3.8%	+8.7%	+9.8%	+11.7%
Apr 9	BMO Capital	Upgrade	Market Perform → Outperform	—	$27.05	$28.00	+3.5%	+4.1%	+1.7%	+0.9%	-2.1%	-3.8%
Apr 2	UBS	Maintains	Neutral → Neutral	—	$28.74	$28.19	-1.9%	-3.9%	-0.0%	-5.0%	-6.0%	-5.9%
Apr 2	Barclays	Maintains	Equal Weight → Equal Weight	—	$28.74	$28.19	-1.9%	-3.9%	-0.0%	-5.0%	-6.0%	-5.9%
Mar 5	UBS	Downgrade	Buy → Neutral	—	$20.19	$19.75	-2.2%	+1.6%	+9.1%	+25.6%	+28.0%	+29.4%

Recent Filings

8-K · 5.02 !!! Very High

The Chemours Company -- 8-K 5.02: Executive Change

Apr 30

8-K · 1.01 ! Medium

Unknown — 8-K 1.01: Financing / Debt Agreement

CC secured new financing through Deutsche Bank, providing capital flexibility that could fund operations or acquisitions, though investors should monitor debt terms and repayment obligations that affect future profitability.

Mar 12

8-K · 8.01 !! High

The Chemours Company -- 8-K 8.01: Material Event / Announcement

Chemours increased its senior unsecured debt offering to $700 million from $600 million, raising additional capital through 7.875% notes maturing in 2034.

Feb 26

8-K

The Chemours Company -- 8-K Filing

Chemours prioritized cash flow over earnings in its Advanced Performance Materials division, resulting in inventory charges and unfavorable product mix that slightly missed adjusted EBITDA guidance despite strong cash generation.

Feb 19

Data updated apr 25, 2026 12:12am · Source: massive.com